Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Drug Use Investigation For Rescriptor (Regulatory Post Marketing Commitment Plan)

NCT00823966 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00823966
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00823966 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Drug Use Investigation For Rescriptor (Regulatory Post Marketing Commitment Plan)
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
December 31, 2003
Completion date
March 31, 2009
Enrollment
3 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1 infection